期刊文献+

颈动脉支架内再狭窄危险因素分析 被引量:5

Risk Factors of In-stent Restenosis after Carotid Artery Stent
下载PDF
导出
摘要 目的评估颈动脉支架术后支架内再狭窄的发生率并分析一些再狭窄可能的危险因素,为临床治疗和预防术后支架内再狭窄(ISRs)提供依据。方法回顾性选择了50例在笔者医院行CAS的患者,收集并分析与支架内狭窄可能相关的临床,影像和手术操作等资料,平均随访2.8年。结果 50例患者中男性占72%(36/50);平均年龄63.1±8.3岁,52处狭窄病变放置60枚支架,术后发生ISRS 7例(13.46%),其中置入两枚支架者ISRS 50%(4/8),置入一枚支架者ISRS 6.82%(3/44)(P<0.05);术后有残余狭窄ISRS 45.45%(5/11),无残余狭窄ISRS 4.88%(2/41)(P<0.05)。多因素回归分析显示,支架内再狭窄与置入支架数量及术后残留狭窄相关(P<0.05)。结论支架置入数量和支架术后残余狭窄可能是ISRS的独立危险因素,根据狭窄病变选择适宜的支架以及尽量减少支架后残余狭窄对防止术后再狭窄至关重要。 Objective To assess the incidence of in - stent restenosis (ISRS) after CAS and to identify some predictors of restenosis and develop effective way to improve clinical treatment and precaution of restenosis. Methods We retrospectively selected 50 treated pa- tients and we obtained and analysis clinical, radiological, and procedural variables to stent restenosis. Mean time of follow - up was 2.8 months. Results CAS was performed in 50 patients,and 72% (36/50) were male. Mean age was 63.1 ± 8.3 years. Seven ( 13.46% ) caces of ISRS ( 〉 50% ) were found by color duplex ultrasound scanning. The ISRS was 50% (4/8) in two pieces of implant stents, 6.82% (3/44) in one stent (P 〈0.05). There were 45.45% (5/11) with residual narrow,and 4.88% (2/41) with no residual narrow (P 〈 O. 05). The correlation analysis demonstrated that in - stent restenosis was correlated to stent quantity and residual stenosis ( P 〈 0. 05). Conclusion The multiple stents deployment and percentage residual stenosis after CAS may be independent predictors of resteno- sis. In our CAS experience, adequate recanalization of the treated vessel and reducing the numbers of implanted stent are important to lim- it the development of stent restenosis.
出处 《医学研究杂志》 2013年第7期137-140,共4页 Journal of Medical Research
关键词 颈动脉支架成形术 支架内再狭窄 危险因素 Carotid artery angioplastyand stenting In -stent restenosis Risk factors
  • 相关文献

参考文献12

  • 1Fairhead JF, Rothwell PM. The need for urgency in identification andtreatment of symptomatic carotid stenosis is already established [ J ].Cerebrovascular Diseases, 2005 ,19(6):355-358.
  • 2CaRESS Steering Committee. Carotid revascularization using endarter-ectomy or stenting systems ( CaRESS)phase 1 clinical trial : 1 yearresults[ J]. J Vase Surg, 2005,42:213-219.
  • 3Robbin ML, Lockhart ME, Weber TM,et al. Carotid artery stents:early and intermediate follow-up with Doppler US [ J ]. Radiology,1997, 205(3):749-756.
  • 4Faught WE, Mattos MA, van Bemmelen PS, et al. Color flow duplexscanning of carotid arteries : new velocity criteria based on receiver opera-tor characteristic analysis for threshold stenoses used in the symptomaticand asymptomatic carotid trials[J]. J Vase Surg, 1994, 19:818-827.
  • 5Ringer AJ, German JW, Guterman LR, et al. Follow-up of stentedcarotid arteries by doppler ultrasound [ J ]. Neurosurgery, 2002 , 51(3):639-643.
  • 6Lai BK, Hobson RW, Goldstein J, et al. Carotid artery stenting : isthere a need to revise ultrasound velocity criteria? [ J]. J Vase Surg,2004,39(1):58-66.
  • 7Arquizan C , Trinquart L, Touboul PJ, et al. EVA-3S Investigators.Restenosis is more frequent after carotid stenting than after endarterec-tomy : the EVA-3S study [ J] . Stroke,2011,42(4):1015-1020.
  • 8Simonetti G, Gandini R, Versaci F, et al. Carotid artery stenting: asingle-centre experience with up to 8 years' followup[ J]. Eur Radi-ol, 2009,19(4):982-989.
  • 9Khan MA, Liu MW, Chio FL, et al. Predictors of restenosis aftersuccessful carotid artery stenting[ J]. Am J Cardiol, 2003,92(7):895-897.
  • 10Willfort-Ehringer A, Ahmadi R, Gessl A, et al. Neointimal prolifera-tion within carotid stents is more pronounced in diabetic patients withinitial poor glycaemic state[ J]. Diabetologia, 2004, 47(3):400-406.

同被引文献49

  • 1凌锋.缺血性脑血管病介入治疗现状和存在的问题[J].实用医院临床杂志,2008,5(2):3-5. 被引量:23
  • 2刘加春,王大明,翟乐乐,姜学丽,王利军.滤网保护装置在颈动脉和椎动脉狭窄支架置入术中的应用[J].中国脑血管病杂志,2005,2(2):68-71. 被引量:10
  • 3江苏省神经病学分会脑血管病学组.关于颅内外动脉狭窄血管成形和支架置入术适应证的建议[J].国外医学(脑血管疾病分册),2005,13(9):643-645. 被引量:18
  • 4Duan Y, Li G, Yang Y, et al. Changes in cerebral hemodynamics after carotid stenting of symptomatic carotid artery [ J ]. Eur J Radiol,2012, 81:744-748.
  • 5CARESS Steering Committee. Carotid revascularization using endarter- ectomy or stenting systems (CARESS) phase 1 clinical trial:l year re- suits[ J]. J Vase Surg,2005 ,42 :213- 219.
  • 6Pathmaja P, Robert IlK, Steven EK, et al. Plasma sterol evidence for decreased absorption and increased synthesis of cholesterol in insulin resistance and obesity [ J ]. Am J Clin Nutr, 2011,94 : 182 -188.
  • 7刘新峰.颈动脉狭窄的介入治[M].脑血管病介入治疗学,2006.225-228.
  • 8Cola C, Brugaletta S, Martin Yuste V, et al. Diabetes mellitus : a pro- thrombotic state Implications for outcomes after coronary revascu|ariza- tion[ J ]. Vascular Heal Risk Manag,2009,5 ( 1 ) : 101-119.
  • 9Lal BK, Beach KW, Roubin GS, et al. Restenosis after carotid artery stenting and endarterectomy: a secondary analysis Of CREST, a ran- domised controlled trial [ J ]. Lancet Neuro1,2012 ,11:755-763.
  • 10Sahara M, Kirigaya H, Oikawa Y, et al. Arterial remodeling patterns before intervention predict diffuse instent restenosis : an intravascular ultrasound study[ J]. J Am Coil Cardio1,2003,42 : 1731-1738.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部